G102958a2021 22iENG
G102958a2021 22iENG
G102958a2021 22iENG
Human Genetics
Code: 102958
ECTS Credits: 4.5
2502442 Medicine OB 2 1
The proposed teaching and assessment methodology that appear in the guide may be subject to changes as a
result of the restrictions to face-to-face class attendance imposed by the health authorities.
Prerequisites
A good knowledge of Catalan and Spanish is indispensable, vehicular languages in which the classes will take
place.
It is advisable that the students have a good knowledge of English, since many of the information sources of
this subject are in this language.
It is convenient that the student has achieved basic skills in Cell Biology, Biochemistry and Molecular Biology.
The subject is scheduled in the second year of the Medicine degree. Its general objective is to give students all
the necessary information that will allow them to acquire knowledge about the organization, function and
regulation of genes in normal conditions and will enable them to understand the mechanisms involved in
genetic-based diseases.
The student will acquire advanced knowledge about human genome; epigenetics and regulation of gene
expression; mutation and repair of DNA; pharmacogenomics; forensic genetics; genetics of development;
inheritance patterns; cytogenetics; rare diseases; cancer genetics and population genetics.
Competences
1
Communicate clearly, orally and in writing, with other professionals and the media.
Critically assess and use clinical and biomedical information sources to obtain, organise, interpret and
present information on science and health.
Demonstrate basic research skills.
Demonstrate understanding of the importance and the limitations of scientific thought to the study,
prevention and management of diseases.
Demonstrate understanding of the mechanisms of alterations to the structure and function of the
systems of the organism in illness.
Demonstrate understanding of the organisation and functions of the genome, the mechanisms of
transmission and expression of genetic information and the molecular and cellular bases of genetic
analysis.
Demonstrate, in professional activity, a perspective that is critical, creative and research-oriented.
Formulate hypotheses and compile and critically assess information for problem-solving, using the
scientific method.
Indicate the basic diagnosis techniques and procedures and analyse and interpret the results so as to
better pinpoint the nature of the problems.
Recognize the determinants of population health, both genetic and dependent on gender, lifestyle, and
demographic, environmental, social, economic, psychological and cultural factors.
Learning Outcomes
Content
Subject contents:
1. Human genome I
2. Human genome II
3. Control of gene expression
4. Epigenetics
5. Variability in gene expression
2
6. Molecular basis of the mutation
7. Mechanisms of DNA repair
8. Pharmacogenomics
Cytogenetics
Inheritance patterns
Population genetics
Genetics of development
Distributive blocks:
I-1. Human genome I: general characteristics, protein coding genes, non-coding RNA genes, splicing, genome
transcription.
I-2. Human genome II: repetitive elements, regulatory elements, genome variability.
I-3. Gene expression: mechanisms of control and regulation of gene expression, microRNA and lncRNA, RNA
editing.
I-4. Epigenetics: epigenetic factors, modification of DNA, modification of histones, inactivation of chromosome
X.
II-6. Molecular bases of the mutation: concept and types of mutations, sequence mutations, structural
mutations, chromosomal mutations, nomenclature of mutations, mutagenic agents.
II-7. Mechanisms of DNA repair: cellular response to genetic damage, main mechanisms of DNA repair,
diseases associated with errors in DNA repair.
II-8. Pharmacogenomics: response to drugs, polymorphisms of metabolizing molecules, transporters and drug
receptors, pharmacological targets.
III-9. Unbalanced structural chromosomal alterations: origin, deletions, duplications, ring chromosomes,
isochromosomes, phenotypic effects, nomenclature.
III-10. Balanced structural chromosomal alterations: pericentric and paracentric inversions: origin, risk of
3
III-10. Balanced structural chromosomal alterations: pericentric and paracentric inversions: origin, risk of
anomalies in offspring; reciprocal translocations: origin, balanced carriers and risk of anomalies in offspring;
Robertsonian translocations: origin, balanced carriers and risk of anomalies in offspring; phenotype of
balanced structural anomalies.
III-11. Numerical chromosomal anomalies: polyploidies; aneuploidies: origin and consequences; mosaics,
trisomies and viable monosomies in the human species, molecular bases of the Down and Turner syndromes.
III-12. Genetic bases of microduplication / deletion syndromesand rare diseases: definition and characteristics,
examples, genetic counseling, genetic analysis.
IV-13. Autosomal inheritance: detection of genetic diseases in medical practice, characteristics and pattern of
transmission of autosomal dominant inheritance, characteristics and transmission pattern of autosomal
recessive inheritance, detection of heterozygotes in the population.
IV-14. Heredity linked to sex: inheritance linked to the recessive and dominant X chromosome, inheritance
linked to the Y chromosome.
IV-15. Multifactorial inheritance: heritability, search for candidate genes, genetic and environmental basis,
normal characters of continuous variability, multifactor alterations with threshold, common diseases that affect
the adult population.
V-17. Population genetics: Hardy-Weinberg law, allelic frequencies, genotypic and phenotypic, calculation of
the frequency of carriers in autosomal recessive and X-linked diseases, factors that alter the Hardy-Weinberg
equilibrium, Hardy-Weinberg equilibrium applied to the profiles of DNA
V-18. Forensic genetics: concept of polymorphism, identification of DNA polymorphisms, applications to the
practice of forensic medicine.
VI-19. Genomic imprint: concept, genes and imprinted chromosomal regions, alterations influenced by
imprinting.
VI-20. Genes of control of embryonic development: general characteristics, transcription factors and signal
molecules, HOX genes.
VII-21. Cancer genetics I: oncogenes and tumor suppressor genes, types of cancer, accumulation of somatic
mutations in the tumor cell, genomic alterations and cancer.
VII-22. Cancer genetics II: carcinogenesis models, solid tumors, hematological neoplasms.
IMPORTANT NOTE: Unless the requirements enforced by the health authorities demand a prioritization or
reduction of these contents
Methodology
Theoretical classes: 22 sessions. Systematized exposition of the syllabus of the subject, giving relevance to
the most important concepts. The students acquire the basic scientific knowledge of the subject in theory
classes, which will complement the personal study of the topics discussed. Students can find a summary of the
material used in class in the Virtual Campus and / or Moodle before or after the lecture.
Seminars: 5 sessions. Exhibition, in small groups, of relevant subjects of the subject and clinical cases. This
methodology will allow students to review the most important or most basic topics necessary for understanding
the subject.
Classroom practices (problems): 4 sessions. Exposition and resolution of cases and genetic problems
presented by the professor.
Laboratory practices: 3 sessions. Exposure and application of the different techniques used in basic and
4
Laboratory practices: 3 sessions. Exposure and application of the different techniques used in basic and
molecular cytogenetics, and their clinical applicability.
IMPORTANT NOTE: Prior to the completion of laboratory practices, students must have completed the test
that certifies the knowledge of the contents of the risk prevention manual and upload it to the Virtual Campus
and / or Moodle. They are essential requirements to perform practices 1 and 2 take a lab coat and show the
teacher a signed copy of the risk prevention test.
IMPORTANT NOTE: The proposed teaching methodology may undergo some modification depending on the
attendance in person restrictions imposed by the health authorities.
Annotation: Within the schedule set by the centre or degree programme, 15 minutes of one class will be
reserved for students to evaluate their lecturers and their courses or modules through questionnaires.
Activities
Type: Directed
CLASSROOM PRACTICES (PAUL) 4 0.16 1, 20, 2, 4, 5, 6, 10, 11, 12, 13, 15, 17
Type: Supervised
Type: Autonomous
Assessment
Evaluation
A. The competences acquired in theory classes, seminars and classroom practices (or genetic problems) of
this subject will be evaluated as follows:
First partial:
• Multiple choice objective test of the knowledge acquired in theory classes (topics 1-12) and seminars 1 and 2.
This test must be passed with a grade of 5 or higher. This test corresponds to 35% of the final grade of the
subject.
Second partial:
5
• Multiple choice objective test of the knowledge acquired in theory classes (topics 13-22) and seminars 3, 4,
and 5. This test must be passed with a grade of 5 or higher. This test corresponds to 35% of the final grade of
the subject.
• Objective written test of questions related to classroom practices. This test corresponds to 10% of the final
grade of the subject.
2. Final exam: Students who are in the following situations may be presented to the final exam:
• Students who have obtained a grade below 5 of the theory part and seminars in any of the two partials.
• Students who have obtained a grade equal to or greater than 5 of the theory part and seminars in both partial
tests but have not passed the subject.
• Students who want to upload a grade of one or both of the partials, or of the classroom practices or problems.
The grade obtained in the final exam will be maintained.
• Multiple choice objective test corresponding to each partial. The student will choose to perform one or both
tests depending on their situation. This test must be passed with a grade of 5 or higher. Each test will
correspond to 35% of the final grade of the subject.
• Objective written test of questions related to classroom practices. This test corresponds to 10% of the final
grade of the subject.
B. The competences acquired in the laboratory practices will be evaluated by continuous evaluation through a
written test at the end of each practice. The average of the three tests corresponding to the three laboratory
practices will be used to obtain the final grade. It is not necessary that the average of the three tests equal or
exceed 5 to pass the course. Failure to show up to practice and, therefore, not perform the corresponding
written test, represents a 0 in that laboratory practice.
The repeating students will only have to return to those lab sessions in which they have not reached a grade
equal to or higher than 6 in the test of the corresponding practice, provided that this mark has been obtained in
the last two years
* To pass the subject it will be necessary to obtain a global grade equal to or greater than 5 out of 10.
* For the final exam, from a score of 4.8 inclusive, it will be possible to make an average between the two
partials if said average is equal to or greater than 5.
* The "Non-evaluable" will reflect the non-attendance to the final exam of recovery for students who have not
passed the subject previously in the partial exams or who have to evaluate the whole subject through the final
exam of recovery.
C. In the case that the student does not exceed the assessment requirements of the subject and its average
grade of is greater than 5, the final grade cannot be higher than 4.8.
D. Those students with three failed calls may apply to perform a special synthesis exam that will include the
entire subject.
6
After each one of the exams of the subject, the review of the exam will be convened during which the students
will be able to consult their exam and, if necessary, make a written and reasoned claim.
IMPORTANT NOTE: The proposed assessment may be modified if the restrictions imposed by the health
authorities require a prioritization or reduction of such content.
Assessment Activities
Lecture: Written assessments through objective tests: 70% 6 0.24 1, 2, 3, 8, 6, 7, 10, 12,
multiple choice items 14, 13, 15, 16, 19
Practice: written assessments through objective tests: 20% 1 0.04 1, 20, 2, 3, 4, 5, 10, 9,
Practical cases solving 11, 12, 15, 18, 17
Problems: written evaluations through objective tests: 10% 1 0.04 3, 10, 14, 13, 15
Problem solving
Bibliography
Bibliography
Specific bibliography:
Peter D. Turnpenny, Sian Ellard. Emery's elements of medical genetics, 15th edition, Elsevier 2018,
ISBN:9788491132066
Lynn B. Jorde, John C. Medical genetics. 5th ed., Elsevier, 2016, ISBN:9788491130581
Tom Strachan, Judith Goodship and Patrick Chinnery. Genetics and genomics in medicine. London : Garland
Science, cop. 2015, ISBN:9780815344803
Tom Strachan and Andrew Read. Human molecular genetics. CRC Press, Taylor & Francis Group, 2019.
ISBN:9780815345893
Ricki Lewis. Human genetics : concepts and applications. New York, NY : McGraw-Hill Education, 2018.
ISBN:9781259700934
Robert L. Nussbaum, Roderick R. McInnes, Huntington F. Willard. Thompson & Thompson Genetics in
Medicine. Elsevier 2016. ISBN:9781437706963
Bruce R. Korf, Mira B. Irons. Human genetics and genomics. 4th edition. Wiley-Blackwell, 2013.
ISBN:9780470654477
Reference bibliography:
Lewis. Human Genetics. Concepts and applications. 9ª ed. McGraw-Hill International edition, 2010
Read A and Donnai D. New Clinical Genetics. 2nd edition. Scion Publishing Ltd, 2011
Internet resources:
http://www.nature.com/nature/supplements/collections/humangenome/index.html.
http://genome.wellcome.ac.uk/
http://www.ncbi.nlm.nih.gov/mapview/map_search.cgi?chr=hum_chr.inf&query
7
http://www.ncbi.nlm.nih.gov/mapview/map_search.cgi?chr=hum_chr.inf&query
http://www.ncbi.nlm.nih.gov/genome/guide/human
http://www.ncbi.nlm.nih.gov/omim
http://www.geneclinics.org
Software
Miscrosoft programs, essentially PowerPoint, will be used to carry out the main lectures. Lecture presentation
and PLAB booklet can be visualized with Adobe Reader.